{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:00:29Z","timestamp":1780110029336,"version":"3.54.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jhep.2006.07.011","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T06:01:00Z","timestamp":1154239260000},"page":"514-519","source":"Crossref","is-referenced-by-count":40,"title":["Insulin resistance and HCV: Will new knowledge modify clinical management?"],"prefix":"10.1016","volume":"45","author":[{"given":"Francesco","family":"Negro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2006.07.011_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.hco.0000231406.84554.96","article-title":"The obesity epidemic and its cardiovascular consequences","volume":"21","author":"Behn","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jhep.2006.07.011_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome \u2013 a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diab Med"},{"key":"10.1016\/j.jhep.2006.07.011_bib3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-004-1335-5","article-title":"The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives","volume":"47","author":"Hills","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2006.07.011_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: a metabolic pathway to chronic liver disease","volume":"42","author":"Bugianesi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2006.07.011_bib6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","article-title":"Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population","volume":"21","author":"Allison","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1464-5491.1995.tb00466.x","article-title":"High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests","volume":"12","author":"Gray","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.jhep.2006.07.011_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004836-199801000-00009","article-title":"Higher incidence of diabetes in liver transplant recipients with hepatitis C","volume":"26","author":"Knobler","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2006.07.011_bib10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00007890-200109270-00015","article-title":"Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality","volume":"72","author":"Baid","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2006.07.011_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.20092","article-title":"New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection","volume":"10","author":"Khalili","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhep.2006.07.011_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/01.TP.0000114283.04840.3A","article-title":"Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation","volume":"77","author":"Delgado-Borrego","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2006.07.011_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2006.07.011_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4065\/75.4.355","article-title":"Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection","volume":"75","author":"Knobler","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2006.07.011_bib15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/diacare.27.5.1171","article-title":"High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury","volume":"27","author":"Lecube","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2006.07.011_bib16","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression","volume":"125","author":"Hui","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.07.011_bib17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.21125","article-title":"Correlation between insulin resistance and hepatitis C viral load","volume":"43","author":"Harrison","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib18","first-page":"179A","article-title":"Hyperinsulinemia blocks the inhibition of hepatitis C virus (HCV) replication by interferon: a potential mechanism for failure of interferon therapy in subjects with HCV and nonalcoholic fatty liver disease","volume":"40","author":"Sanyal","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-Gomez","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.07.011_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2362.2000.00608.x","article-title":"Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha","volume":"30","author":"Konrad","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhep.2006.07.011_bib21","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signalling 3","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2006.07.011_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.07.011_bib23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.hep.2003.09.012","article-title":"Impaired IRS-1\/PI3-kinase signalling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/qjmed\/hci001","article-title":"TNF-\u03b1, chronic hepatitis C and diabetes: a novel triad","volume":"98","author":"Knobler","year":"2005","journal-title":"Q J Med"},{"key":"10.1016\/j.jhep.2006.07.011_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2006.02729.x","article-title":"Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection","volume":"23","author":"De Gottardi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2006.07.011_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jhep.2004.09.022","article-title":"Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients","volume":"42","author":"Muzzi","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3","volume":"33","author":"Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitic C: Why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib29","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2006.07.011_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis","volume":"16","author":"Perlemuter","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2006.07.011_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2004.12.034","article-title":"An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation","volume":"42","author":"Abid","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib32","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2006.02.035","article-title":"Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis","volume":"130","author":"Mirandola","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.07.011_bib33","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2006.07.011_bib34","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/jhep.2002.36370","article-title":"Hepatitis C virus genotype 3 is cytopathic to hepatocytes. Genotype-specific reversal of hepatic steatosis after sustained response to antiviral therapy","volume":"36","author":"Kumar","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","article-title":"Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/hep.20664","article-title":"Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients","volume":"41","author":"Adinolfi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510290401","article-title":"Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis","volume":"29","author":"Hourigan","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"Fartoux","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib40","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.2003.018770","article-title":"Steatosis affects chronic hepatitis C progression in a genotype-specific way","volume":"53","author":"Rubbia-Brandt","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.52.2.288","article-title":"Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies","volume":"52","author":"Castera","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0168-8278(02)00299-4","article-title":"Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients","volume":"37","author":"Westin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jhep.2003.11.004","article-title":"The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients","volume":"40","author":"Patton","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib44","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"The relationship between hepatic steatosis, inflammation and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.07.011_bib45","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0168-8278(03)00456-2","article-title":"Fibrogenic impact of high serum glucose in chronic hepatitis C","volume":"39","author":"Ratziu","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib46","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0168-8278(03)00463-X","article-title":"In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy","volume":"39","author":"Hickman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib47","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/gut.52.11.1638","article-title":"Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C","volume":"52","author":"Asselah","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib48","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/gut.51.3.434","article-title":"Fatigue is associated with high circulating leptin levels in chronic hepatitis C","volume":"51","author":"Piche","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/gut.52.6.915","article-title":"Fatigue is associated with high circulating leptin levels in chronic hepatitis C","volume":"52","author":"Romero-Gomez","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib50","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/S0168-8278(06)80535-0","article-title":"Is connective tissue growth factor (CTGF) the missing link between steatosis, insulin resistance and fibrosis in patients with chronic hepatitis C?","volume":"44","author":"Hora","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib51","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1053\/j.gastro.2003.08.029","article-title":"Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin","volume":"125","author":"Kamada","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2006.07.011_bib52","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1210\/jc.2004-1266","article-title":"Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients","volume":"90","author":"Petit","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhep.2006.07.011_bib53","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0168-8278(96)80286-8","article-title":"A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C","volume":"25","author":"Ziol","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.07.011_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gut.51.1.7","article-title":"Weighty issues in hepatitis C","volume":"51","author":"Heathcote","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib55","first-page":"210","article-title":"Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis","volume":"23","author":"Larrea","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.07.011_bib56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/gut.2005.069674","article-title":"Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1","volume":"55","author":"Walsh","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0952-7915(00)00228-4","article-title":"Signalling by type I and II cytokine receptors: ten years after","volume":"13","author":"Gadina","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jhep.2006.07.011_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/gut.51.1.89","article-title":"Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C","volume":"51","author":"Hickman","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2006.07.011_bib59","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2006.07.011_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2004.01888.x","article-title":"Metformin in the treatment of patients with non-alcoholic steatohepatitis","volume":"19","author":"Uygun","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2006.07.011_bib61","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2006.07.011_bib62","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.HYP.0000036396.64769.C2","article-title":"Antiinflammatory and antiarteriosclerotic effects of pioglitazone","volume":"40","author":"Ishibashi","year":"2002","journal-title":"Hypertension"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806003886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806003886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T18:54:00Z","timestamp":1547492040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827806003886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0168827806003886"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2006.07.011","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}